TBI-223 enteric capsule: Clinical Trials

1 trial of TBI-223 enteric capsule, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow TBI-223 enteric capsule: new trials by email Literature Review of TBI-223 enteric capsule trials Research Report on TBI-223 enteric capsule

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults
TBI-223 oral suspension, TBI-223 enteric capsule, TBI-223 SR Tablet Prototype 1 - Tuberculosis, Tuberculosis, Pulmonary
Phase 1CompletedGlobal Alliance for TB Drug Development862019-01-162024-12-09

Conditions studied

Tuberculosis (1)  ·  Tuberculosis, Pulmonary (1)

Sponsors

Global Alliance for TB Drug Development (1)

Countries

United States (1)

Top investigators

Jerry Nedelman (1)

Results publications

PMID 40067046